Personalis, Inc
The Sr. Manager / Associate Director of Quality Events provides strategic leadership and program governance over the company’s Nonconformance, CAPA, Planned Deviation, and Quality Investigation systems. This role ensures strict compliance with FDA and global regulatory requirements while driving organizational maturity from reactive compliance to proactive, data-driven prevention. The position involves presenting critical quality metrics to executive leadership and championing continuous process improvement across Clinical Laboratory Operations, Assay Development, and Manufacturing/Supply Chain.
Headquarters
Fremont, California, United States
Company Size
201-500 employees
Founded
2011
Personalis is a genomics company transforming the active management of cancer through advanced ctDNA (circulating tumor DNA) technologies. Their solutions enable highly sensitive liquid biopsy testing, supporting applications from molecular residual disease (MRD) detection to therapy selection. Personalis serves oncology-focused customers seeking actionable cancer insights through cutting-edge sequencing and bioinformatics.
Personalis, Inc. (NASDAQ:PSNL) Receives Average Recommendation of "Moderate Buy" from Analysts
1 day ago
Personalis Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights
2 weeks ago
Personalis to Announce Fourth Quarter and Full Year 2025 Financial Results
1 month ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Personalis, Inc.
With 42% ownership, Personalis, Inc. (NASDAQ:PSNL) has piqued the interest of institutional investors
Sep 18, 2025